A Giant Heterometallic Polyoxometalate Nanocluster for Enhanced Brain‐Targeted Glioma Therapy
Angewandte Chemie International Edition · 04.03.2024 · 63 (10)
DOI: 10.1002/anie.202319700 ↗Kurz gefasst
Fachartikel in der Zeitschrift Angewandte Chemie International Edition, online erschienen am 26.01.2024. Verfasst von Nizi Song und 7 weiteren Autor:innen. Beteiligte Einrichtung: Henan Key Laboratory of Polyoxometalate Chemistry, College of Chemistry and Molecular Sciences, Henan University, Kaifeng, Henan, 475004, China. Hauptthemen laut MEDLINE: Glioma, Brain Neoplasms, Polyelectrolytes, Anions. Die Arbeit wurde bisher 75-mal zitiert (Crossref) und nennt 51 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National Natural Science Foundation of China-Shanxi Joint Fund for Coal-Based Low-Carbon Technology, Program for Science & Technology Innovation Talents in Universities of Henan Province.
Abstract (Originalsprache)
Giant heterometallic polyoxometalate (POM) clusters with precise atom structures, flexibly adjustable and abundant active sites are promising for constructing functional nanodrugs. However, current POM drugs are almost vacant in orthotopic brain tumor therapy due to the inability to effectively penetrate the blood–brain barrier (BBB) and low drug activity. Here, we designed the largest (3.0 nm × 6.0 nm) transition‐metal–lanthanide co‐encapsulated POM cluster {[Ce 10 Ag 6 (DMEA)(H 2 O) 27 W 22 O 70 ][B‐ α ‐TeW 9 O 33 ] 9 } 2 88− featuring 238 metal centers via synergistic coordination between two geometry‐unrestricted Ce 3+ and Ag + linkers with tungsten‐oxo cluster fragments. This POM was combined with brain‐targeted peptide to prepare a brain‐targeted nanodrug that could efficiently traverse BBB and target glioma cells. The Ag + active centers in the nanodrug specifically activate reactive oxygen species to regulate the apoptosis pathway of glioma cells with a low half‐maximal inhibitory concentration (5.66 μM). As the first brain‐targeted POM drug, it efficiently prolongs the survival of orthotopic glioma‐bearing mice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Henan Key Laboratory of Polyoxometalate Chemistry, College of Chemistry and Molecular Sciences, Henan University, Kaifeng, Henan, 475004, China.
- Academy for Advanced Interdisciplinary Studies, Henan Key Laboratory of Brain Targeted Bio-nanomedicine, School of Life Sciences, Henan University, Kaifeng, Henan, 475004, China.
- State Key Laboratory of Cotton Biology, School of Life Sciences, Henan University, Kaifeng, Henan, 475004, China.
ORCID-Profile: Junwei Zhao
Förderung
- National Natural Science Foundation of China
- National Natural Science Foundation of China-Shanxi Joint Fund for Coal-Based Low-Carbon Technology
- Program for Science & Technology Innovation Talents in Universities of Henan Province
- Program for Kaifeng Innovation Teams of Science and Technology
- Science and Technology Innovation Talents in Universities of Henan Province
Zitieren
APA
Song, N., Lu, M., Liu, J., Lin, M., Shangguan, P., Wang, J., Shi, B., & Zhao, J. (2024). A Giant Heterometallic Polyoxometalate Nanocluster for Enhanced Brain‐Targeted Glioma Therapy. Angewandte Chemie International Edition, 63(10). https://doi.org/10.1002/anie.202319700
Vancouver
Song N, Lu M, Liu J, Lin M, Shangguan P, Wang J, et al. A Giant Heterometallic Polyoxometalate Nanocluster for Enhanced Brain‐Targeted Glioma Therapy. Angewandte Chemie International Edition. 2024;63(10). doi:10.1002/anie.202319700
BibTeX
@article{Song2024,
author = {Song, Nizi and Lu, Mengya and Liu, Jiancai and Lin, Ming and Shangguan, Ping and Wang, Jiefei and Shi, Bingyang and Zhao, Junwei},
title = {A Giant Heterometallic Polyoxometalate Nanocluster for Enhanced Brain‐Targeted Glioma Therapy},
journal = {Angewandte Chemie International Edition},
year = {2024},
volume = {63},
number = {10},
doi = {10.1002/anie.202319700}
}
EUVIMED